Crossmark

Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome

Crossref DOI link: https://doi.org/10.1007/s00277-021-04667-w

Published Online: 2021-09-25

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yildirim, Nazim

Unal, Selma

Yalcinkaya, Ahmet https://orcid.org/0000-0002-1172-3330
Karahan, Feryal

Oztas, Yesim
License Information

Text and Data Mining valid from 2021-09-25

Version of Record valid from 2021-09-25
More Information

Article History

Received: 28 January 2021

Accepted: 15 September 2021

First Online: 25 September 2021

Declarations

:

: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Ethical approval for the study was obtained from the Clinical Research Ethics Committee of Mersin University Faculty of Medicine (Decision number: 78017789/050.01.04/529310).

: Informed consent was obtained from all patients for being included in the study. All patients or their caretakers signed written informed consent forms when they were admitted to the ward.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below